Rapid Communication Open Access
Copyright ©2007 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 28, 2007; 13(48): 6588-6592
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6588
Predictive value of D-dimer for portal vein thrombosis after portal hypertension surgery in hepatitis B virus-related cirrhosis
Mei-Hai Deng, Bo Liu, He-Ping Fang, Wei-Dong Pan, Zhao-Feng Tang, Peng Deng, Yue-Si Zhong, Rui-Yun Xu, Department of Hepato-biliary Surgery, Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, Guangdong Province, China
Supported by Technology Support Fund of Guangdong Province, No. 2004B35001007
Correspondence to: Dr. Mei-Hai Deng, Department of Hepato-biliary Surgery, Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, Guangdong Province, China. drdmh@medmail.com.cn
Telephone: +86-20-85613318 Fax: +86-20-85262937
Received: October 11, 2007
Revised: November 15, 2007
Accepted: November 26, 2007
Published online: December 28, 2007

Abstract

AIM: To evaluate the predictive value of D-dimer as a predictive indicator of portal vein thrombosis (PVT) after portal hypertension surgery in hepatitis B virus-related cirrhosis.

METHODS: A prospective study was carried out in 52 patients who had undergone surgery for portal hypertension in hepatitis B virus-related cirrhosis. Changes in perioperative dynamic D-dimer were observed. The sensitivity, specificity, positive predictive values and negative predictive values of D-dimer were calculated, and ROC curves were analyzed.

RESULTS: The D-dimer levels in the group developing postoperative PVT was significantly higher than those in the group not developing PVT (P = 0.001), and the ROC semi-quantitative and qualitative analysis of D-dimer showed a moderate predictive value in PVT (semi-quantitative value Az = 0.794, P = 0.000; qualitative analysis: Az = 0.739, P = 0.001).

CONCLUSION: Dynamic monitoring of D-dimer levels in patients with portal hypertension after surgery can help early diagnosis of PVT, as in cases where the D-dimer levels steadily increase and exceed 16 μg/mL, the possibility of PVT is very high.

Key Words: Portal hypertension; Portal vein thrombosis; Splenectomy; D-dimer; Diagnosis



INTRODUCTION

Portal vein thrombosis (PVT) is a significant postoperative complication in patients with portal hypertension, and procedures such as devascularization, portal systemic shunt and liver transplantation can cause PVT[1-3]. As the degree of obstruction and location vary greatly, the clinical manifestations of PVT are also highly variable[4-6]. Depending on the severity of the condition, it may even result in death of patients.

The incidence of PVT after portal hypertension surgery ranges from 22.2%-37.5%[1,7], depending on the surgical techniques used and patients selected. In China, the most common cause for portal hypertension is liver cirrhosis due to hepatitis B. There is an increasing trend in PVT after portal hypertension surgery for hepatitis B liver cirrhosis.

Currently, diagnosis of portal vein thrombosis is mainly based on imaging studies[8-10], especially colour Doppler ultrasound, because of its ability to provide not only information on blood vessel location, blood flow rate and direction, but also haemodynamic information, which aids diagnosis accuracy[11,12]. It is able to provide information on the thrombosed veins via echo analysis, detect the presence of post-stenotic dilatation, as well as flow defects and turbulence due to venous thrombosis[13,14]. Although portal vein thrombosis can be accurately diagnosed using this method, it produces side effects simultaneously. Therefore, the focus of clinicians is to prevent portal vein thrombosis after portal hypertension surgery as early as possible, the early predictive indicator of postoperative PVT is still lacking.

Currently, clinicians use the incrteased platelet count as the main deciding factor for initiating prophylactic treatment, but the prognostic value of platelet count in PVT is debatable[15,16]. Some studies showed that even at the time of portal vein thrombosis formation, the level of platelet count has not yet reached 500 × 109/L, and patients showing increased levels of platelet count do not have portal vein thrombosis[17]. Hence, the question of the indicator for initiation of preventive and therapeatic measures is still debatable.

Clotting factors are important in the assessment of liver function and have certain clinical significance, but have yet to show a good clinical value as a diagnostic indicator for thrombotic diseases. At present, D-dimer, the molecular marker in the fibrinolysis cycle, has shown a good negative and positive predictive value in thrombotic diseases such as deep vein thrombosis in the lower limbs and pulmonary embolism, and has therefore been used in studies on its clinical application[18,19]. However, since patients with portal hypertension due to liver cirrhosis have innate clotting and fibrinolytic disorders[20,21], more studies are required to show whether D-dimer has a better predictive value PVT after portal hypertension surgery due to the combined effects of portal vein thrombosis on platelets, clotting and fibrinolysis[22].

MATERIALS AND METHODS
Patient selection criteria

Patients who were admitted to the Third Affiliated Hospital of the Sun Yat-Sen University from September 2004 to March 2006, and diagnosed with portal hypertension due to liver cirrhosis (hepatitis B) were included in this study. The patients with splenomegalia and hypersplenia underwent splenectomy, and the patients with esophageal variceal bleeding underwent splenectomy with gastroesophageal devascularization, or with endoscopic variceal ligation (EVL). Patients who underwent portal hypertension shunting surgery, liver transplant patients, and patients having concurrent liver cirrhosis and hepatocellular carcinoma, and patients diagnosed with PVT before surgery, were excluded from this study.

General demographics

A total of 52 patients (46 males and 6 females) fulfilled the selection criteria. Their age ranged from 20-60 years, with a median age of 46 years (Table 1). Surgical procedures performed on patients included splenectomy and gastroesophageal devascularization (Hassab's operation) as previously described[23]. In brief, an extended left subcostal incision or a L incision of the left upper abdomen was used for extreme splenomegaly. After routine splenectomy, the gastric branch and 5-8 small branches of the gastric coronary veins were disconnected. The esophageal branch was disconnected and suture-ligated. The gastric posterior vein was ligated by suturing, and the left subphrenic vein was ligated as well. In cases of splenectomy with EVL, after splenectomy, an endoscope (GIF 240 or 260, Olympus Optical, Tokyo) was introduced during operation. Ligation was carried out 6-12 times by placing a single rubber band (Bard Interventional Products, Tewksbury, Mass.) over a varix.

Table 1 Characteristics of 52 patients studied.
ThrombusNon-thrombusP value
Age ( mean ± SD )41.45 ± 10.8344.3 ± 8.650.388
GenderMale1531
Female240.649
Child's grade of Liver functionGrade A612
Grade B10210.997
Grade C12
Surgical procedureSplenectomy713
Splenectomy + EVL19190.923
Splenectomy + ligation213
Diagnosis of PVT

When colour Doppler ultrasonography imaging showed changes consistent with thrombus formation in the main portal vein, right portal vein, right anterior branch, right posterior branch, left portal vein, left horizontal branch, left sagittal portion, splenic vein, proximal and distal mesenteric vein, PVT was confirmed to be a complication after surgery.

Measurement of D-dimer levels

Dynamic D-dimer changes in 52 patients were monitored perioperatively, and the portal vein patency and the incidence of PVT were detected routinely by color Doppler ultrasonography from 7 to 14 d postoperatively. The 52 patients were divided into thrombosis group and non-thrombosis group, depending on the occurrence of PVT after surgery. Peripheral venous blood was collected perioperatively. Three mL blood was centrifuged at 1000 r/min for 15 min before plasma was prepared for D-dimer detection. D-dimer was detected by latex-agglutination assay (semi-quantitative method), and the reagent was provided by Shanghai Sun Company, and the procedure was performed following the instructions provided with the reagent pack.

Statistical analysis

After normality tests, D-dimer indicators showing a skewed distribution were subjected to signed rank test between the thrombosis and non-thrombosis groups, using the difference in the median and interquartile range to illustrate the central and disperse tendency. Chi-square test was used to analyze the dispersion. Sensitivity, specificity, positive and negative predictive value were calculated. ROC curve was plotted. Statistical analysis was performed using the SPSS software version 13.0 for Windows.

RESULTS
Characteristics of the 52 patients studied

Of the 52 patients, 17 developed PVT after surgery, and the incidence of PVT 7-14 d after portal hypertension surgery was 33.69%. There was no significant statistical difference in age, gender, liver function and surgical procedure between the thrombosis and non-thrombosis groups (Table 1).

Perioperative D-dimer level

The D-dimer level was significantly higher in the thrombosis group than in the non-thrombus group on day 5 after surgery (P = 0.001) (Table 2).

Table 2 D-dimer level in the thrombosis and non-thrombosis groups (μg/mL).
Before surgeryDay 1after surgeryDay 5 aftersurgery
Non-thrombus group1 (0.5, 2)4 (2, 8)14 (2, 4)12
Thrombus group1 (0.5, 2)4 (2, 8)18 (4, 8)13
Z value1.8630.3183.264
P value0.0620.7510.001
Analysis of predictive value for D-dimer in PVT after surgery

By using the change in D-dimer level post-surgery (used as the standard) and the D-dimer (used as semi-quantitative standard) as the diagnostic standard for PVT in liver cirrhosis patients after portal hypertension surgery, we achieved 37.5% accuracy in predicting PVT incidence, which is consistent with the reported data[1]. The sensitivity (Sen), specificity (Spe), positive predictive value (PPV) and negative predictive value (NPV) are listed in Table 3. It can be seen from Table 3 that the positive predictive value was 66.7% for the D-dimer one day after surgery, and the negative predictive value for the continuous increasing was 77.5%, which was significantly higher than the semi-quantitative value of 61.65% for PPV and 70.83% for NPV. Under the extreme circumstances, the semi-quantitative value for PPV and NPV was 100%, respectively.

Table 3 Diagnostic value for different D-dimer diagnostic standards (%).
SensitivitySpecificityPPVNPV
Qualitative standardNo decrease Increase88.2 47.0657.14 88.5742.85 66.6788.25 77.50
Semi-quantitative standard> 0.5 > 11 10 0.0571437.50 38.880 100
> 20.82350.48584982.00
> 40.41180.857161.6570.83
> 80.23531100.0033.89
> 160.23531100.0033.89

Based on the different changes in D-dimer levels and the false positive rates and sensitivity rates under different D-dimer levels, a ROC curve was plotted. The semi-quantitative and qualitative standards for ROC curve are shown in Figure 1. Using the ROC analysis, the area under the semi-qualitative ROC curve was Az = 0.794, P = 0.000, and the 95% confidence level was 0.794 ± 0.114. The area under the qualitative ROC curve was Az = 0.739, P = 0.001, and the 95% confidence level was 0.795 ± 0.146. Both standards had a median diagnostic value, and there was no statistical significant difference in the areas under the ROC curve (Z = 0.586, P = 0.719).

Figure 1
Figure 1 Semi-quantitative and qualititive ROC curves.
DISCUSSION

D-dimer is an antigenic determinant of fibrin, which, at the D-region, combines with factor XIIIa, and persists as an X-oligopolymer, as well as with other fibrin degradation products. However, it does not exist with profibrin breakdown products, and is a specific indicator of synthesis and breakdown of fibrin in the system. An increasing D-dimer level indicates active clotting and fibrinolysis in the system[24,25].

At present, D-dimer has a good negative and positive predictive value, which is used in the outpatient and emergency setting, to aid selective diagnosis of suspected thrombotic diseases[19,26-28]. Risch et al[29] reported that at D-dimer levels of 1 μg/mL and 10 μ/mL (VIDAS DD), the sensitivity is 83.3% and 23.8%, respectively, and the specificity is 65.8% and 98.7%, respectively. In our study, the D-dimer level was higher than the reported level in liver cirrhosis patients after portal hypertension surgery, measured at similar sensitivity conditions, but had a lower specificity than the reported one. This may be attributed to the hyperactive state of the coagulation pathway due to the high coagulability state in liver cirrhosis patients, activated fibrinolysis, blood products used perioperatively, and trauma due to surgery[20-22,30].

Dynamic D-dimer value monitoring during the early stages after portal hypertension surgery may be more useful in achieving a meaningful diagnosis of PVT due to thrombosis formation. By analyzing the D-dimer after surgery and its predictive value for PVT, our study proved that the positive predictive value was 100% at ≥ 16 μg/mL (Table 3). From the ROC curve (Figure 1), we could see that the qualitative standard was situated towards the left upper side of the semi-quantitative standard ROC curve, showing a higher sensitivity, but a lower rate of false positive response. Under the two extreme ends, the semi-quantitative standard curve was on the left-hand-side of the qualitative ROC curve, suggesting that the former may have a better diagnostic value. Therefore, combining semi-quantitative and qualitative measurement may be the best option for diagnosing PVT in liver cirrhosis patients after portal hypertension surgery.

In conclusion, D-dimer is an early predictive indicator of PVT after portal hypertension surgery in hepatitis B virus-related cirrhosis. Dynamic D-dimer monitoring should be performed perioperationly, and if elevation of the D-dimer levels persists or exceeds 16 μg/mL, PVT may occur, and anti-coagulation prevention and treatment should be considered.

COMMENTS
Background

Portal vein thrombosis (PVT) is a significant complication after portal hypertension surgery due to liver cirrhosis. The focus of clinicians is to prevent it as early as possible, but we still lack the early predictive indicator of postoperative PVT.

Research frontiers

PVT is a significant postoperative complication in patients with portal hypertension, especially after splenectomy. Since the mechanism of postoperative PVT remains unknown, it is difficult to prevent postoperative PVT. Most studies indicate that local operation may be the factor for postoperative PVT. Some studies indicate that D-dimer may be helpful in the diagnosis of deep vein thrombosis of lower extremity.

Innovations and breakthroughs

At present, most researchers and doctors diagnose PVT via imageology, especially color Doppler ultrasonography, and some reports indicate that platelets may be the predictive factor for PVT. D-dimer is a good predictive factor for deep vein thrombosis of lower extremity. The results of our study indicate that D-dimer may be a predictive factor for PVT after portal hypertension surgery in hepatitis B virus-related cirrhosis.

Applications

Since D-dimer is a predictive factor for PVT, PVT and its fatal complications can be prevented. By combining imageology, we can institute a scheme for the management of PVT, which helps to understand the mechanism of PVT.

Terminology

D-dimer: known as fragment D-dimer, fibrin degradation fragment; PVT: portal vein thrombosis. ROC curve: a graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons.

Peer review

This is a well-conducted study. It describes another way for the predictive diagnosis of PVT, but the relationship between the mechanisms of PVT and D-dimer remains unknown. D-dimer is only of a predictive diagnostic value.

Footnotes

S- Editor Liu Y L- Editor Wang XL E- Editor Wang HF

References
1.  Dai ZB, Peng ZH. Portal hypertension and portal venous thrombosis. Puwai Linchuang. 1993;8:150-152.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Mercado MA, Orozco H, Guillén-Navarro E, Acosta E, López-Martínez LM, Hinojosa C, Hernández J, Tielve M. Small-diameter mesocaval shunts: a 10-year evaluation. J Gastrointest Surg. 2000;4:453-457.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 18]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
3.  Settmacher U, Nüssler NC, Glanemann M, Haase R, Heise M, Bechstein WO, Neuhaus P. Venous complications after orthotopic liver transplantation. Clin Transplant. 2000;14:235-241.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 151]  [Cited by in F6Publishing: 132]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
4.  Wang MC, Li S, Zhu JY, Leng XS, Du RY. [The reason and treatment of portal vein thrombosis in patients with portal hypertension postoperation]. Zhonghua Waike Zazhi. 2004;42:269-271.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  de Cleva R, Herman P, Saad WA, Pugliese V, Zilberstein B, Rodrigues JJ, Laudanna AA. Postoperative portal vein thrombosis in patients with hepatosplenic mansonic schistosomiasis: relationship with intraoperative portal pressure and flow. A prospective study. Hepatogastroenterology. 2005;52:1529-1533.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32:466-470.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 342]  [Cited by in F6Publishing: 360]  [Article Influence: 15.0]  [Reference Citation Analysis (0)]
7.  Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, Musha H, Takashi M, Suzuki N, Shinagawa T. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology. 1985;89:279-286.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Kreft B, Strunk H, Flacke S, Wolff M, Conrad R, Gieseke J, Pauleit D, Bachmann R, Hirner A, Schild HH. Detection of thrombosis in the portal venous system: comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography. Radiology. 2000;216:86-92.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 92]  [Cited by in F6Publishing: 95]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
9.  Shah TU, Semelka RC, Voultsinos V, Elias J Jr, Altun E, Pamuklar E, Firat Z, Gerber DA, Fair J, Russo MW. Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidates. Liver Transpl. 2006;12:1682-1688.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 25]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
10.  Ikeda M, Sekimoto M, Takiguchi S, Kubota M, Ikenaga M, Yamamoto H, Fujiwara Y, Ohue M, Yasuda T, Imamura H. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg. 2005;241:208-216.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 202]  [Cited by in F6Publishing: 217]  [Article Influence: 11.4]  [Reference Citation Analysis (0)]
11.  Yerdel MA, Gunson B, Mirza D, Karayalçin K, Olliff S, Buckels J, Mayer D, McMaster P, Pirenne J. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation. 2000;69:1873-1881.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 485]  [Cited by in F6Publishing: 487]  [Article Influence: 20.3]  [Reference Citation Analysis (0)]
12.  Tarantino L, Francica G, Sordelli I, Esposito F, Giorgio A, Sorrentino P, de Stefano G, Di Sarno A, Ferraioli G, Sperlongano P. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging. 2006;31:537-544.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 124]  [Cited by in F6Publishing: 114]  [Article Influence: 6.7]  [Reference Citation Analysis (0)]
13.  Tessler FN, Gehring BJ, Gomes AS, Perrella RR, Ragavendra N, Busuttil RW, Grant EG. Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR Am J Roentgenol. 1991;157:293-296.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 130]  [Cited by in F6Publishing: 131]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
14.  Rossi S, Rosa L, Ravetta V, Cascina A, Quaretti P, Azzaretti A, Scagnelli P, Tinelli C, Dionigi P, Calliada F. Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR Am J Roentgenol. 2006;186:763-773.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 108]  [Cited by in F6Publishing: 114]  [Article Influence: 6.3]  [Reference Citation Analysis (0)]
15.  Ziemski JM, Rudowski WJ, Jaskowiak W, Rusiniak L, Scharf R. Evaluation of early postsplenectomy complications. Surg Gynecol Obstet. 1987;165:507-514.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Lee JJ, Kim HJ, Chung IJ, Park MR, Seo KS, Jeong YY, Kim JK. Portal, mesenteric, and splenic vein thromboses after splenectomy in a patient with chronic myeloid leukemia variant with thrombocythemic onset. Am J Hematol. 1999;61:212-215.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Winslow ER, Brunt LM, Drebin JA, Soper NJ, Klingensmith ME. Portal vein thrombosis after splenectomy. Am J Surg. 2002;184:631-635; discussion 631-635;.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 128]  [Cited by in F6Publishing: 139]  [Article Influence: 6.3]  [Reference Citation Analysis (0)]
18.  Rathbun SW, Whitsett TL, Raskob GE. Negative D-dimer result to exclude recurrent deep venous thrombosis: a management trial. Ann Intern Med. 2004;141:839-845.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 55]  [Cited by in F6Publishing: 57]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
19.  Gardiner C, Pennaneac'h C, Walford C, Machin SJ, Mackie IJ. An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis. Br J Haematol. 2005;128:842-848.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 35]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
20.  Violi F, Ferro D, Basili S, Saliola M, Quintarelli C, Alessandri C, Cordova C. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology. 1995;109:531-539.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 90]  [Cited by in F6Publishing: 92]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
21.  Colucci M, Binetti BM, Branca MG, Clerici C, Morelli A, Semeraro N, Gresele P. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology. 2003;38:230-237.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 102]  [Cited by in F6Publishing: 95]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
22.  Hunt BJ, Parratt RN, Segal HC, Sheikh S, Kallis P, Yacoub M. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg. 1998;65:712-718.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 114]  [Cited by in F6Publishing: 109]  [Article Influence: 4.2]  [Reference Citation Analysis (0)]
23.  Yang Z, Qiu F. [Pericardial devascularization with splenectomy for the treatment of portal hypertension]. Zhonghua Waike Zazhi. 2000;38:645-648.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Fimognari FL, De Santis A, Piccheri C, Moscatelli R, Gigliotti F, Vestri A, Attili A, Violi F. Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. J Lab Clin Med. 2005;146:238-243.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 48]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
25.  Hafner JW, Gerdes E, Aldag JC. Combining clinical risk with D-dimer testing to rule out acute deep venous thrombosis (DVT). J Emerg Med. 2006;30:100-101.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 3]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
26.  Dempfle C, Schraml M, Besenthal I, Hansen R, Gehrke J, Korte W, Risch M, Quehenberger P, Handler S, Minar E. Multicentre evaluation of a new point-of-care test for the quantitative determination of D-dimer. Clin Chim Acta. 2001;307:211-218.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 25]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
27.  Legnani C, Fariselli S, Cini M, Oca G, Abate C, Palareti G. A new rapid bedside assay for quantitative testing of D-Dimer (Cardiac D-Dimer) in the diagnostic work-up for deep vein thrombosis. Thromb Res. 2003;111:149-153.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 13]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
28.  Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003;349:1227-1235.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 999]  [Cited by in F6Publishing: 854]  [Article Influence: 40.7]  [Reference Citation Analysis (0)]
29.  Risch L, Monn A, Lüthy R, Honegger H, Huber AR. The predictive characteristics of D-dimer testing in outpatients with suspected venous thromboembolism: a Bayesian approach. Clin Chim Acta. 2004;345:79-87.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 19]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
30.  Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol. 2006;12:2115-2119.  [PubMed]  [DOI]  [Cited in This Article: ]